Topical ganciclovir in the treatment of acute herpetic keratitis
Open Access
- 1 August 2010
- journal article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 4, 905-12
Abstract
Peer reviewed article authored by (Khalid F Tabbara, Noorjehan Al Balushi). Read article or submit your manuscript for publishing.Keywords
This publication has 30 references indexed in Scilit:
- Therapeutic interventions for herpes simplex virus epithelial keratitis2007
- Dipeptide Monoester Ganciclovir Prodrugs for Treating HSV-1-Induced Corneal Epithelial and Stromal Keratitis: In Vitro and In Vivo EvaluationsJournal of Ocular Pharmacology and Therapeutics, 2005
- Treatment of Herpetic KeratitisOphthalmology, 2005
- Primary Graft Failure Caused by Herpes Simplex Virus Type 1Cornea, 2001
- Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.British Journal of Ophthalmology, 1996
- Recurrence and Resistance Patterns of Herpes Simplex Virus following Cessation of >=6 Years of Chronic Suppression with AcyclovirThe Journal of Infectious Diseases, 1994
- Ganciclovir Ophthalmic Gel in Herpes Simplex Virus Rabbit Keratitis: Intraocular Penetration and EfficacyJournal of Ocular Pharmacology and Therapeutics, 1994
- 2′-Nor-2′-deoxyguanosine is an effective therapeutic agent for treatment of experimental herpes keratitisAntiviral Research, 1987
- Anti-herpes simplex virus (HSV) effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) in rabbit corneaCurrent Eye Research, 1987
- 2′-nor-cGMP, a new cyclic derivative of 2′NDG, inhibits HSV-1 replicationin vitroand in the mouse keratitis modelCurrent Eye Research, 1987